Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2025)

Dianthus Therapeutics' Shares Outstanding history runs 9 years deep, the most recent figure standing at $43.2 million for Q4 2025.

• In Q4 2025, Shares Outstanding rose 38.91% year-over-year to $43.2 million; the TTM figure through Dec 2025 stood at $43.2 million (up 38.91% YoY), while the FY2025 annual figure was $43.2 million, up 38.91% from the prior year.
• Shares Outstanding was $43.2 million for Q4 2025 at Dianthus Therapeutics, up from $42.9 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $58.8 million in Q3 2021 to a low of $875279.0 in Q4 2021.
• Historically, Shares Outstanding has averaged $29.6 million across 5 years, with a median of $32.1 million in 2025.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding surged 37374.03% in 2021, then plunged 91.53% in 2022.
• A 5-year view of Shares Outstanding shows it stood at $10.3 million in 2021, then slumped by 91.53% to $875279.0 in 2022, then surged by 1592.91% to $14.8 million in 2023, then jumped by 109.99% to $31.1 million in 2024, then jumped by 38.91% to $43.2 million in 2025.
• The last three Shares Outstanding figures came in at $43.2 million (Q4 2025), $42.9 million (Q3 2025), and $32.2 million (Q2 2025), per Business Quant data.